NO20045657L - Fremgangsmate ved fremstilling av fast doseringsform for desmopressin - Google Patents

Fremgangsmate ved fremstilling av fast doseringsform for desmopressin

Info

Publication number
NO20045657L
NO20045657L NO20045657A NO20045657A NO20045657L NO 20045657 L NO20045657 L NO 20045657L NO 20045657 A NO20045657 A NO 20045657A NO 20045657 A NO20045657 A NO 20045657A NO 20045657 L NO20045657 L NO 20045657L
Authority
NO
Norway
Prior art keywords
desmopressin
solid dosage
dosage form
preparation
pharmaceutically acceptable
Prior art date
Application number
NO20045657A
Other languages
English (en)
Norwegian (no)
Other versions
NO20045657D0 (no
Inventor
Hans Lindner
Kristian Wannerberger
Lars-Erik Olsson
Ann Elisabeth Svensson
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34560171&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20045657(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO20045657D0 publication Critical patent/NO20045657D0/no
Publication of NO20045657L publication Critical patent/NO20045657L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20045657A 2003-12-29 2004-12-27 Fremgangsmate ved fremstilling av fast doseringsform for desmopressin NO20045657L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03029897A EP1550439B1 (fr) 2003-12-29 2003-12-29 Procédé pour la préparation d'une forme solide de dosage de Desmopressine

Publications (2)

Publication Number Publication Date
NO20045657D0 NO20045657D0 (no) 2004-12-27
NO20045657L true NO20045657L (no) 2005-06-30

Family

ID=34560171

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045657A NO20045657L (no) 2003-12-29 2004-12-27 Fremgangsmate ved fremstilling av fast doseringsform for desmopressin

Country Status (12)

Country Link
EP (1) EP1550439B1 (fr)
AR (1) AR047155A1 (fr)
AT (1) ATE319430T1 (fr)
DE (1) DE60303872T2 (fr)
DK (1) DK1550439T3 (fr)
ES (1) ES2254858T3 (fr)
HK (1) HK1079696A1 (fr)
IL (3) IL202881A0 (fr)
NO (1) NO20045657L (fr)
PT (1) PT1550439E (fr)
SI (1) SI1550439T1 (fr)
TW (1) TWI282284B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
CA2584456C (fr) * 2006-03-02 2008-07-22 Ferring International Center S.A. Composition avec desmopressine
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
LT2712622T (lt) 2008-05-21 2016-09-26 Ferring B.V. Burnoje disperguojamas desmopresinas, skirtas nikturijos netrikdomo miego pirminio periodo pailginimui
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018602A1 (fr) * 1994-01-11 1995-07-13 Alkermes Controlled Therapeutics, Inc. FORME PHARMACEUTIQUE DE DESMOPRECYNE (dDAVP) POUR ADMINISTRATION PAR VOIE ORALE
SK1732004A3 (sk) * 2001-10-15 2005-06-02 R�Hm Gmbh & Co. Kg Použitie kopolyméru na prípravu liekovej formy, ktorá ako účinnú látku obsahuje peptid alebo proteín
DE60307082T4 (de) * 2002-05-07 2015-04-30 Ferring B.V. In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin

Also Published As

Publication number Publication date
NO20045657D0 (no) 2004-12-27
DE60303872D1 (de) 2006-05-04
SI1550439T1 (sl) 2006-08-31
PT1550439E (pt) 2006-06-30
IL165780A0 (en) 2006-01-15
TW200528141A (en) 2005-09-01
IL202881A0 (en) 2011-07-31
TWI282284B (en) 2007-06-11
ATE319430T1 (de) 2006-03-15
IL189107A0 (en) 2008-06-05
AR047155A1 (es) 2006-01-11
HK1079696A1 (en) 2006-04-13
DE60303872T2 (de) 2006-10-19
EP1550439B1 (fr) 2006-03-08
DK1550439T3 (da) 2006-04-03
ES2254858T3 (es) 2006-06-16
EP1550439A1 (fr) 2005-07-06

Similar Documents

Publication Publication Date Title
WO2004082615A3 (fr) Procede de preparation de comprimes a liberation prolongee
WO2005107721A3 (fr) Forme galenique pharmaceutique et procede de fabrication de celle-ci
NO20073959L (no) Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller
DE60328722D1 (de) Verfahren zur herstellung von tannat-tabletten, kapseln oder anderen festen dosierformen
HRP20090194T1 (en) Dry granulated composition comprising emtricitabine and tenofovir df
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
ATE516796T1 (de) Granulat mit einem pharmazeutischen wirkstoff und einem emulgator und herstellungsverfahren dafür
WO2006082501A3 (fr) Procede de formation rapide de masse humide pour la preparation de compositions contenant du calcium
RU2008135718A (ru) Композиции клопидогреля бисульфата
DK1373207T3 (da) Nyt amlodipincamsylat og fremgangsmåde til fremstilling heraf
RU2015117523A (ru) Комбинированный препарат, содержащий гемиглиптин и метформин, и способ его получения
WO2008100240A3 (fr) Composition pharmaceutique avec du laurylsulfate de sodium en tant que promoteur d'absorption/de compression extra granulaire, et son procédé de fabrication
WO2003026610A3 (fr) Procede de preparation d'une forme posologique a dissolution rapide
DE60306120D1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
FI3769765T3 (fi) Natriumalkyylisulfaattia sisältävä farmaseuttinen koostumus
WO2006123243A3 (fr) Formes galeniques pharmaceutiques d'un antidepresseur
NO20053368D0 (no) Fremgangsmate for fremstilling av en farmasoytisk ren polymorf I av olanzapin.
TW200740424A (en) Taste masking dosage form
NO20045657L (no) Fremgangsmate ved fremstilling av fast doseringsform for desmopressin
WO2003086362A3 (fr) Comprimes d'hydrochlorure de bupropion stables
JP2006342148A5 (fr)
WO2009135950A3 (fr) Procédé pour préparer un comprimé contenant des excipients
AP2277A (en) Process for production of 1,2,2,2-tertafluoro ethyl difluoro methyl ether.
JP2009091362A5 (fr)
WO2010130393A3 (fr) Comprimé à fondre contenant un sel de vardenafil

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application